Owning a pet has become significantly more expensive since the beginning of 2020. Across the veterinary sector, service prices have drastically outpaced general consumer inflation and the rising costs of other service industries. While a sharp spike in pet ownership during the COVID-19 pandemic triggered a surge in demand, antitrust experts are pointing to a structural shift within the industry as a major driver behind the soaring bills: rapid corporate consolidation.
The independent watchdog monitoring these developments, the Danish Competition and Consumer Authority, has launched a focused analysis into how the competitive sector is shifting. Historically, the veterinary market was dominated by independent, locally owned clinics. Over the last few years, however, private equity funds and large corporate groups have quietly bought up a relatively high number of these clinics, absorbing them into expansive corporate networks.
From an antitrust perspective, this wave of acquisitions directly threatens local market dynamics. When multiple neighborhood clinics are brought under a single corporate owner, market concentration spikes and choice diminishes. This leaves pet owners with fewer independent alternatives. The authority’s preliminary antitrust analysis indicates that this reduction in local competition gives consolidated entities greater leverage to hike prices, particularly in specific geographic pockets where a single private equity group holds a near-monopoly on emergency or standard care.
The rising cost of keeping pets healthy has not gone unnoticed by the public. The antitrust regulator revealed it has received a growing number of inquiries and complaints regarding potential competition issues within the sector. Because veterinary care is an essential service for millions of families, artificial price inflation directly compromises consumer welfare. The Danish Competition and Consumer Authority has signaled that it will continue to actively police competitive conditions in the industry, keeping a close eye on whether corporate buyer power is being used to unfairly squeeze pet owners.
Furthermore, this scrutiny is part of a broader, ongoing global trend, as Antitrust Intelligence had already been closely analyzing and tracking the corporate roll-up strategy in the veterinary sector well before the current wave of public complaints. Read our latest analysis.
